Transform the rare disease landscape by pioneering the launch of a revolutionary in vivo CRISPR therapy. Drive commercial success through strategic territory management, scientific education, and cross-functional collaboration in a competitive market.

Contribute to the launch of a first-ever in vivo CRISPR therapy, developing strategic relationships with healthcare providers in key states, and driving sales in a dynamic, competitive landscape while ensuring effective territory management and scientific communication.

Shape the future of rare disease treatment by leading the sales efforts for an innovative CRISPR therapy. Engage with healthcare professionals, manage key relationships, and educate on cutting-edge therapeutic solutions within a competitive market.

Empower groundbreaking therapies by leading the activation of treatment sites. Drive strategic initiatives, foster collaboration, and enhance patient access through visionary leadership and operational excellence.